Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of innovative therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is co... Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of innovative therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The firm's pipeline includes investigational product candidates that affect heme biosynthesis and iron metabolism. Show more
WATERTOWN, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of...
Completed a successful end of Phase 2 meeting with the FDA for bitopertin in erythropoietic protoporphyria (EPP), reaching alignment on all proposed study parameters with the potential for...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.25 | 0.401284109149 | 62.3 | 66.73 | 56.28 | 268105 | 59.72005651 | CS |
4 | 15.7 | 33.5112059765 | 46.85 | 68.73 | 44.81 | 435734 | 58.08777052 | CS |
12 | 13.02 | 26.287098728 | 49.53 | 68.73 | 44.69 | 297829 | 53.4029933 | CS |
26 | 30.47 | 94.9812967581 | 32.08 | 68.73 | 30.65 | 306698 | 47.46599619 | CS |
52 | 12.05 | 23.8613861386 | 50.5 | 77.6 | 25.6 | 342180 | 47.92535329 | CS |
156 | 41.66 | 199.42556247 | 20.89 | 77.6 | 15 | 255682 | 46.33077143 | CS |
260 | 41.66 | 199.42556247 | 20.89 | 77.6 | 15 | 255682 | 46.33077143 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales